BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7715856)

  • 1. Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity.
    Widzowski DV; Finkelstein JN; Pokora MJ; Cory-Slechta DA
    Neurotoxicology; 1994; 15(4):853-65. PubMed ID: 7715856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional alterations in dopamine systems assessed using drug discrimination procedures.
    Cory-Slechta DA; Widzowski DV; Pokora MJ
    Neurotoxicology; 1993; 14(2-3):105-14. PubMed ID: 8247385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment.
    Zuch CL; O'Mara DJ; Cory-Slechta DA
    Toxicol Appl Pharmacol; 1998 May; 150(1):174-85. PubMed ID: 9630467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead.
    Kala SV; Jadhav AL
    Neurotoxicology; 1995; 16(2):297-308. PubMed ID: 7566689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
    Cory-Slechta DA; Pokora MJ; Fox RA; O'Mara DJ
    Neurotoxicology; 1996; 17(2):445-57. PubMed ID: 8856740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain.
    Choi SJ; Mazzio E; Kolta MG; Soliman KF
    Ann N Y Acad Sci; 1998 May; 844():293-302. PubMed ID: 9668686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dopaminergic activity, but not tyrosine hydroxylase, is diminished after chronic inorganic lead exposure.
    Lasley SM
    Neurotoxicology; 1992; 13(3):625-35. PubMed ID: 1361980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth.
    El-Khodor BF; Boksa P
    Exp Neurol; 1997 May; 145(1):118-29. PubMed ID: 9184115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
    Cory-Slechta DA; O'Mara DJ; Brockel BJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):794-805. PubMed ID: 9694936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 2,4-dichlorophenoxyacetic acid exposure on dopamine D2-like receptors in rat brain.
    Bortolozzi AA; Evangelista De Duffard AM; Duffard RO; Antonelli MC
    Neurotoxicol Teratol; 2004; 26(4):599-605. PubMed ID: 15203183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneity of regional brain lead concentrations.
    Widzowski DV; Cory-Slechta DA
    Neurotoxicology; 1994; 15(2):295-307. PubMed ID: 7991218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity.
    Cory-Slechta DA
    Neurotoxicology; 1997; 18(3):673-88. PubMed ID: 9339816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
    Pokora MJ; Richfield EK; Cory-Slechta DA
    J Neurochem; 1996 Oct; 67(4):1540-50. PubMed ID: 8858938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens.
    Goeders NE; Kuhar MJ
    Alcohol Drug Res; 1987; 7(4):207-16. PubMed ID: 2950865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
    Bauter MR; Brockel BJ; Pankevich DE; Virgolini MB; Cory-Slechta DA
    Neurotoxicology; 2003 Mar; 24(2):227-43. PubMed ID: 12606295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-induced changes in dopamine receptors in early postnatal rat brain.
    Mukda S; Kaewsuk S; Ebadi M; Govitrapong P
    Dev Neurosci; 2009; 31(3):193-201. PubMed ID: 19145071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens.
    Nye HE; Hope BT; Kelz MB; Iadarola M; Nestler EJ
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1671-80. PubMed ID: 8531143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.